Formulation and evaluation of vinylpyrrolidone/vinylacetate copolymer microspheres with carbamazepine

被引:32
作者
Moneghini, M
Voinovich, D
Princivalle, F
Magarotto, L
机构
[1] Univ Trieste, Dept Pharmaceut Sci, I-34127 Trieste, Italy
[2] Univ Trieste, Dept Earth Sci, I-34127 Trieste, Italy
[3] Vectorpharma SpA, I-34100 Trieste, Italy
关键词
carbamazepine; dissolution enhancement; microspheres; vinylpyrrolidone/vinylacetate copolymer;
D O I
10.1081/PDT-100100550
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Vinylpyrrolidone/vinylacetate copolymer (VP/VAc) was used for the enhancement of dissolution rate of carbamazepine, an antiepileptic drug characterized by very low water solubility. Microspheres containing different drug-to-polymer ratios were prepared using a solvent-evaporation technique and their physical characterizations were carried out by differential scanning calorimetry, x-ray diffractometry, and scanning electron microscopy. Through the solubilization kinetics and dissolution rates studies, the in vitro drug availability of the microspheres was evaluated. These results showed that the dissolution of carbamazepine in gastrointestinal fluids from all of the prepared formulations was increased with respect to the drug itself. However, the best dissolution parameters were obtained from 1:10 w/w system because of the presence of the drug in amorphous form and its efficient encapsulation.
引用
收藏
页码:347 / 353
页数:7
相关论文
共 16 条
[1]  
Aboul-Enein H.Y., 1980, ANAL PROFILES DRUG S, V9, P87
[2]   HEAT OF FUSION MEASUREMENT OF A LOW MELTING POLYMORPH OF CARBAMAZEPINE THAT UNDERGOES MULTIPLE-PHASE CHANGES DURING DIFFERENTIAL SCANNING CALORIMETRY ANALYSIS [J].
BEHME, RJ ;
BROOKE, D .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (10) :986-990
[3]  
*CASF CORP, 1993, KOLL POL PHARM IND
[4]   Carbamazepine and polyethylene glycol solid dispersions: Preparation, in vitro dissolution, and characterization [J].
Doshi, DH ;
Ravis, WR ;
Betageri, GV .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1997, 23 (12) :1167-1176
[5]  
DUGUE J, 1991, PHARM ACTA HELV, V66, P307
[6]  
Giunchedi P, 1990, Boll Chim Farm, V129, P17
[7]   PHARMACOKINETICS AND DISSOLUTION OF 2 CRYSTALLINE FORMS OF CARBAMAZEPINE [J].
KAHELA, P ;
AALTONEN, R ;
LEWING, E ;
ANTTILA, M ;
KRISTOFFERSSON, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1983, 14 (01) :103-112
[8]  
KRAHN FU, 1987, PHARM ACTA HELV, V62, P247
[9]  
LEFEBVRE C, 1987, PHARM ACTA HELV, V62, P341
[10]  
LEVY RH, 1975, CLIN PHARMACOL THER, V17, P657